ArticleFrontiers in public health2025
The burden of carbon monoxide poisoning in China from 1990 to 2021 and forecasts to 2050.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This study aimed to analyze the disease burden of carbon monoxide poisoning (COP) in China from 1990 to 2021 and to forecast future trends. Methods: Data were retrieved from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021. The incidence, prevalence, mortality, and Disability Adjusted Life Years (DALYs) and their corresponding Age-Standardized Rates (ASRs) were examined to assess the burden of COP in China from 1990 to 2021. The Joinpoint regression model was used to investigate the trend changes of COP burden. The Age-Period-Cohort model was employed to delineate age, period, and cohort effects on the trends in disease burden. The Bayesian Age-Period-Cohort analysis method was applied to predict the changing trends of COP disease burden in China from 2022 to 2050. Results: In 2021, there were 152,820 incidences COP in China, with an Age-Standardized Incidence Rate (ASIR) of 13.06 per 100,000 population. There were 13,289 fatalities, corresponding to an Age-Standardized Mortality Rate (ASMR) of 0.8 per 100,000 population. The total DALYs amounted to 499,528, with an Age-Standardized DALY Rate (ASDR) of 35.02 per 100,000 population. The peak burden, as measured by DALYs, was observed in the 30-34 age group. Trend analysis employing Joinpoint regression revealed an initial increase in ASIR and Age-Standardized Prevalence Rate (ASPR) until 2015, followed by a subsequent decline. Moreover, the ASMR and ASDR showed fluctuant downward trends. Predictions from the Bayesian Age-Period-Cohort model suggest that the incidence, prevalence, mortality, and DALYs of COP in China are expected to increase from 2022 to 2050, peaking in 2038, while the ASRs are projected to decline. Conclusion: From 1990 to 2021, China experienced dynamic temporal patterns in the burden of COP, characterized by an initial rise in incidence and prevalence, followed by a decline in recent years, alongside a general downward trajectory in mortality and DALYs. Additionally, projections indicate a potential resurgence in COP-related burden in the coming decades.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.